1. To evaluate the long-term clinical outcomes and prognostic factors in patients with coronary artery disease undergoing coronary artery bypass graft surgery. 2. To evaluate the long-term clinical outcomes and prognostic factors in patients with coronary artery disease undergoing percutaneous coronary intervention with drug-eluting stent.
Coronary artery disease (CAD) still remains one of the world's leading causes of death, despite markedly improvement of devices and technologies on past several decades. The treatment strategy for CAD included medical treatment, percutaneous coronary intervention (PCI), and coronary-artery bypass grafting (CABG). CABG is a procedure in which autologous arteries or veins are used as grafts to bypass coronary arteries that are partially or completely obstructed by atherosclerotic plaque. During the past decade, there has been nearly a 30% decline in CABG procedures, despite abundant evidence to support the effectiveness and safety of the operation.This decline has been accompanied by a corresponding increase in PCI. To date, there have been numerous studies to compare the clinical outcomes between PCI and CABG for patients with CAD. Among them, SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) trial demonstrated CABG is associated with lower incidence of major adverse cardiac and cerebrovascualr events in patients with high SYNTAX score, compared with PCI. In this regard, the current guidelines recommend that CABG is preferred method for care of stable ischemic heart disease patients with three-vessel or left main coronary artery disease. However, most randomized controlled studies do not reflect the contemporary practice, because they have been performed in the era of bare metal stents or first-generation drug-eluting stent (DES). In addition, there have been limited data regarding the prognostic factors for long-term clinical outcomes in patients undergoing PCI with DES or CABG. Therefore, the investigators sought to compare the clinical outcomes between PCI with DES or CABG, and to identify prognostic factors for long-term clinical outcomes in patients who underwent PCI with DES or CABG.
Study Type
OBSERVATIONAL
Enrollment
10,000
Samsung Medical Center
Seoul, South Korea
RECRUITINGCardiac Death
death from cardiac-cause
Time frame: 5-Year after the index procedure
All-cause Death
death from any-cause
Time frame: 5-Year after the index procedure
Myocardial infarction
Myocardial infarction without peri-procedural myocardial infarction
Time frame: 5-Year after the index procedure
Target-vessel revascularization
ischemia-driven or all
Time frame: 5-Year after the index procedure
Any revascularization
ischemia-driven or all
Time frame: 5-Year after the index procedure
Bleeding
BARC type 2-5
Time frame: 5-Year after the index procedure
Cerebrovascular accident
Ischemic or hemorrhagic
Time frame: 5-Year after the index procedure
MACCE (major adverse cardiac and cerebrovascular accident)
a composite of death, myocardial infarction, and cerebrovascular accident
Time frame: 5-Year after the index procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.